Organic Anion Transporting Polypeptide Although this P-tau antibody is being evaluated in clinical trial for the treatment, diagnosis, and prevention of neurodegenerative disease (clinical trial “type”:”clinical-trial”,”attrs”:”text”:”NCT04096287″,”term_id”:”NCT04096287″NCT04096287), the upstream mechanisms underlying P-tau induction are still unknown tuskonus April 10, 2023